Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
The only definitive way to diagnose and stage lung cancers is through biopsies
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
Ayush market has reached US $18 billion from meager US $3 billion under guidance and visionary leadership of our Prime Minister
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
Acquisition expands Merck’s growing hematology portfolio
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
The product is expected to be launched by Q4 FY23.
Subscribe To Our Newsletter & Stay Updated
